An attorney who handled a prominent negligence case against a Kentucky compounder advises veterinarians and horse owners to make sure they are acting legally when administering a compounded drug to a horse.
In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Accelerate Springs Stunning Upset as Arrogate Falters
- Lady Eli Runs 'One of Her Greatest Races to Date'
- Firenze Fire Upsets Sanford Stakes
- Twisted Tom Muscles His Way to New York Derby Score
- Always Dreaming, Cloud Computing, Tapwrit Work at Spa
- Hunt Overcomes Trouble to Win Eddie Read
- As Arrogate's Stature Builds, So Do Expectations
- Maryland Horse of the Year Ben's Cat Dies
- Dream It Is The Real Deal in Schuylerville
- Kettle Corn Gets First Winner at Belterra Park